Key result
In patients with deep venous thrombosis and malignant tumors, non-survivors had significantly higher D-dimer levels (9.2 vs 3.1 µg/mL, P<0.01), more proximal DVT, and more advanced clinical stages.
Why the study?
What are the prognostic factors for mortality in patients with deep venous thrombosis complicated by malignant tumors?
Observational (n=59)
No
What are the prognostic factors for mortality in patients with deep venous thrombosis complicated by malignant tumors?
In patients with DVT and malignant tumors, higher D-dimer and FDP levels, proximal DVT location, and advanced clinical stage are significant predictors of mortality.
悪性腫瘍に静脈血栓症が合併することはしばしば見受けられる．今回，当科で経験した深部静脈血栓症（dvt）を合併した悪性腫瘍症例を検討した．
No takes yet. Share an insight, caveat, or question.
Sato et al. (2018) conducted an observational in Deep venous thrombosis and malignant tumors (n=59). Non-survival (death) vs. Survival was evaluated on D-dimer levels (µg/mL) (p=<0.01). In patients with deep venous thrombosis and malignant tumors, non-survivors had significantly higher D-dimer levels (9.2 vs 3.1 µg/mL, P<0.01), more proximal DVT, and more advanced clinical stages.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: